Evli Bank Plc
EVLI BANK PLC STOCK EXCHANGE RELEASE FEBRUARY 22, 2020, 1.15 PM. (EET/EEST)
The Board of Directors of Evli Bank Plc has in its meeting on January 22, 2021 approved a request of a shareholder to convert 7,600 Series A shares of Evli Bank Plc to Series B shares in accordance with Article 4 in the Articles of Association.
As a result of the conversion of shares, the company’s amount of Series A shares totals 14,627,664 and the amount of Series B shares totals 9,481,756. The conversion does not affect the total amount of shares which is 24,109,420. The number of votes of the company's shares is after the conversion 302,035,036.
The conversions of shares were registered in the Trade Register on February 22, 2021. The converted shares will be listed on the Nasdaq Helsinki together with the old shares on February 23, 2021.
EVLI BANK PLC
Juho Mikola
CFO
For additional information, please contact:
Daniela Wahlberg, Senior Specialist, Communications, Evli Bank Plc, tel. +358 50 401 7714, daniela.wahlberg@evli.com
Evli Bank Plc
Evli is a bank specialized in investments that helps institutions, corporations and private persons increase their wealth. The product and service offering includes mutual funds, asset management and capital markets services, alternative investment products, equity research, incentive plan design and administration as well as Corporate Finance services. The company also offers banking services that support clients' investment operations. Evli is the highest ranked and most used institutional asset manager in Finland*.
Evli has a total of EUR 14.1 billion in client assets under management (net 12/2020). Evli Group's equity capital totals EUR 95.4 million and its BIS capital adequacy ratio is 15.2 percent (December 31, 2020). The company has around 250 employees. Evli Bank Plc's B shares are listed on Nasdaq Helsinki Ltd.
*KANTAR SIFO Prospera External Asset Management Finland 2015, 2016, 2017, 2018, 2019 and SFR Scandinavian Financial Research Institutional Investment Services, Finland 2015, 2016, 2017, 2018.
Distribution: Nasdaq Helsinki Ltd, main media, www.evli.com
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Maytronics17.10.2025 15:00:00 CEST | Press release
Dolphin Liberty 600 by Maytronics Named to TIME’s List of the Best Inventions of 2025
Evaxion17.10.2025 14:15:51 CEST | Press release
Evaxion reports 75% Objective Response Rate in phase 2 trial with AI-designed personalized cancer vaccine EVX-01
WillScot17.10.2025 14:00:00 CEST | Press release
WillScot Closes Amended and Extended Asset-Based Revolving Credit Facility
Novartis Pharma AG17.10.2025 14:00:00 CEST | Press release
Novartis Kisqali® 5-year NATALEE data demonstrate 28% reduction in risk of recurrence in the broadest early breast cancer patient population
Sanofi Winthrop Industrie17.10.2025 13:05:00 CEST | Press release
Press Release: Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom